New Council members elected, 2021
The ASCI is pleased to announce the results of a recent ballot to fill Council vacancies. Dr. Priscilla Hsue, Secretary-Treasurer Elect, oversaw the ballot; Drs. Sara E. Cosgrove and Ralph J. DeBerardinis volunteered as auditors.
The following members will join the Council at the conclusion of the upcoming AAP/ASCI/APSA Joint Meeting, April 8-10.
Vice President: Benjamin D. Humphreys, MD, PhD
Dr. Humphreys is Chief of the Division of Nephrology at Washington University in St. Louis and the Joseph P. Friedman Professor of Renal Diseases in Medicine. His research focuses on the cellular and molecular mechanisms of kidney injury and repair. Elected to the ASCI in 2013, he served as the ASCI’s 2019-2021 Secretary-Treasurer.
Councilor: Julie Anne Bastarache, MD
Dr. Bastarache is a Pulmonary and Critical Care translational physician-scientist at Vanderbilt University Medical Center and the Department of Veterans Affairs. Her research focuses on mechanisms that drive acute lung, brain and kidney injury in sepsis and critical illness. Dr. Bastarache was elected to the ASCI in 2020.
Councilor: Goutham Narla, MD, PhD
Dr. Narla is the Division Chief of Genetic Medicine at the University of Michigan and an Associate Professor of Internal Medicine at Michigan Medicine. His research focuses on the study of the structural and molecular basis for tumor suppressor gene inactivation in cancer initiation, development and progression. Dr. Narla was elected to the ASCI in 2016.
Councilor: Elizabeth K. Speliotes, MD, PhD, MPH
Dr. Speliotes is the Keith Henley Endowed Professor of Gastroenterology and Computational Medicine and Bioinformatics at the University of Michigan. She conducts large-scale genomic studies of obesity and nonalcoholic fatty liver disease to identify genetic variants that predispose to disease and define disease subtypes. Dr. Speliotes was elected to the ASCI in 2013.
